CLOROX CO /DE/ (CLX) Form 10-Q — Nov 2, 2026
Clorox reported Q1 FY27 net sales of $1,905 million, up 33% year-over-year, with diluted EPS of $1.39 versus $0.65 a year ago (+114%).
Key figures
- Eps
- 1.39
- Revenue
- 1905
- Net Income
- 170
- Total Debt
- 5158
- Revenue Yoy
- 33%
- Total Assets
- 7832
- Cash Position
- 184
- Shares Outstanding
- 121147396
- Gross margin
- 40.4%
- Gojo goodwill
- $716 million
- Dividends paid
- $151 million
- Interest expense
- 52
- Buybacks remaining
- $876 million
- Effective tax rate
- 16.4%
- Gross margin change
- -130 bps
- Operating cash flow
- 143
- Organic sales growth
- 18%
- Segment adjusted EBIT
- 284
- Revolving credit capacity
- $1,964 million
- Gojo purchase consideration
- $2,147 million cash
- Commercial paper outstanding
- $1,175 million
- Dividends per share declared
- 2.5
- Health and wellness sales growth
- 62%
- Burts bees trademark carrying value
- $322 million
- Current liabilities exceed current assets
- $1,023 million
AI analysis
Red flags6 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.